Get the Stockscreener App
30.65
2.17%
0.65
Fulgent Genetics Inc stock is traded at $30.65, with a volume of 515.39K.
It is up +2.17% in the last 24 hours and up +29.11% over the past month.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
See More
Previous Close:
$30.00
Open:
$30.01
24h Volume:
515.39K
Relative Volume:
1.90
Market Cap:
$947.46M
Revenue:
$290.71M
Net Income/Loss:
$-163.43M
P/E Ratio:
-5.5931
EPS:
-5.48
Net Cash Flow:
$11.70M
1W Performance:
+6.39%
1M Performance:
+29.11%
6M Performance:
+50.91%
1Y Performance:
+71.52%
1-Day Range:
$29.55
$30.67
1-Week Range:
$28.29
$30.67
52-Week Range:
$14.76
$30.67
Fulgent Genetics Inc Stock (FLGT) Company Profile
Name
Fulgent Genetics Inc
Sector
Industry
Phone
626-350-0537
Address
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
30.65 | 927.37M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-05-25 | Upgrade | UBS | Neutral → Buy |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-08-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-18-22 | Initiated | Raymond James | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Feb-04-22 | Resumed | Piper Sandler | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Underperform |
| Jan-08-21 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-20-20 | Initiated | Oppenheimer | Outperform |
| May-29-20 | Initiated | BTIG Research | Buy |
| Nov-05-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Mar-01-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Nov-07-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Fulgent Genetics Inc Stock (FLGT) Latest News
Have Insiders Sold Fulgent Genetics Shares Recently? - simplywall.st
Fulgent Genetics (NASDAQ:FLGT) COO Sells $291,000.00 in Stock - MarketBeat
[Form 4] Fulgent Genetics, Inc. Insider Trading Activity - Stock Titan
Can Fulgent Genetics Inc. (7F0) stock test all time highsMarket Performance Summary & Daily Momentum Trading Reports - newser.com
How Fulgent Genetics Inc. (7F0) stock reacts to new regulationsJuly 2025 Summary & Expert Approved Momentum Trade Ideas - newser.com
Why Fulgent Genetics Inc. stock appeals to analysts2025 Dividend Review & Fast Gaining Stock Strategy Reports - newser.com
Published on: 2025-11-19 17:53:16 - newser.com
How analysts revise price targets for Fulgent Genetics Inc. (7F0) stockJuly 2025 Patterns & Fast Gain Stock Trading Tips - newser.com
Will Fulgent Genetics Inc. (7F0) stock outperform value peers2025 Market Sentiment & Weekly Watchlist for Hot Stocks - newser.com
Is Fulgent Genetics Inc. (7F0) stock among top earnings playsQuarterly Profit Report & Expert Approved Momentum Ideas - newser.com
Is Fulgent Genetics Inc. stock resilient to inflationWeekly Investment Report & Free Risk Controlled Daily Trade Plans - newser.com
Can Fulgent Genetics Inc. (7F0) stock resist broad market declinesWeekly Profit Recap & Capital Efficiency Focused Ideas - newser.com
Does Fulgent Genetics Inc. (7F0) stock trade below intrinsic valueOptions Play & Real-Time Volume Spike Alerts - newser.com
Can Fulgent Genetics Inc. stock resist sector downturns2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com
Momentum divergence signals in Fulgent Genetics Inc. chartMarket Activity Recap & Free Weekly Chart Analysis and Trade Guides - newser.com
Multi factor analysis applied to Fulgent Genetics Inc.July 2025 EndofMonth & Pattern Based Trade Signal System - newser.com
Can Fulgent Genetics Inc. stock resist market sell offsJuly 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com
Campbell & CO Investment Adviser LLC Purchases 9,217 Shares of Fulgent Genetics, Inc. $FLGT - MarketBeat
Fulgent Genetics (FLGT) Price Target Increased by 32.90% to 34.34 - Nasdaq
Is Fulgent Genetics Inc. stock undervalued vs historical averagesJuly 2025 Patterns & Community Supported Trade Ideas - newser.com
What dividend safety score for Fulgent Genetics Inc. stockWatch List & Weekly Momentum Picks - newser.com
Will Fulgent Genetics Inc. stock benefit from upcoming earnings reportsJuly 2025 News Drivers & Stock Market Timing Techniques - newser.com
Fulgent Genetics (NASDAQ: FLGT) Developments and S&P 500 Market - Kalkine Media
Fulgent Genetics (NASDAQ:FLGT) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Fulgent Genetics Inc Stock (FLGT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):